<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31337508</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2163</ISSN><JournalIssue CitedMedium="Internet"><Volume>344</Volume><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cellular immunology</Title><ISOAbbreviation>Cell Immunol</ISOAbbreviation></Journal><ArticleTitle>Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.</ArticleTitle><Pagination><StartPage>103949</StartPage><MedlinePgn>103949</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cellimm.2019.103949</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0008-8749(19)30037-1</ELocationID><Abstract><AbstractText>PAR4 is expressed by a variety of cells, including platelets, cardiac, lung and immune cells. We investigated the contribution of PAR4 to viral infections of the heart and lung. Toll-like receptor (TLR) 3-dependent immune responses were analyzed after co-stimulation of PAR4 in murine bone-marrow derived macrophages, embryonic fibroblasts and embryonic cardiomyocytes. In addition, we analyzed Coxsackievirus B3 (CVB3) or H1N1 influenza A virus (H1N1 IAV) infection of PAR4<sup>-/-</sup> (&#x394;PAR4) and wild-type (WT) mice. Lastly, we investigated the effect of platelet inhibition on H1N1 IAV infection. In vitro experiments revealed that PAR4 stimulation enhances the expression of TLR3-dependent CXCL10 expression and decreases TLR3-dependent NF&#x3ba;B-mediated proinflammatory gene expression. Furthermore, CVB3-infected &#x394;PAR4 mice exhibited a decreased anti-viral response and increased viral genomes in the heart leading to more pronounced CVB3 myocarditis compared to WT mice. Similarly, H1N1 IAV-infected &#x394;PAR4 mice had increased immune cell numbers and inflammatory mediators in the lung, and increased mortality compared with infected WT controls. The study showed that PAR4 protects mice from viral infections of the heart and lung.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tatsumi</LastName><ForeName>Kohei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis Program, Division of Hematology and Oncology, UNC McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmedes</LastName><ForeName>Clare M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis Program, Division of Hematology and Oncology, UNC McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houston</LastName><ForeName>E Reaves</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis Program, Division of Hematology and Oncology, UNC McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis Program, Division of Hematology and Oncology, UNC McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackman</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Thrombosis and Hemostasis Program, Division of Hematology and Oncology, UNC McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniak</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: antoniak@email.unc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL119523</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL142799</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Cell Immunol</MedlineTA><NlmUniqueID>1246405</NlmUniqueID><ISSNLinking>0008-8749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054357">Chemokine CXCL10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485433">Cxcl10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018179">Receptors, Thrombin</NameOfSubstance></Chemical><Chemical><RegistryNumber>JWE1M73YZN</RegistryNumber><NameOfSubstance UI="C112908">protease-activated receptor 4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054357" MajorTopicYN="N">Chemokine CXCL10</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018179" MajorTopicYN="N">Receptors, Thrombin</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">Innate immune responses</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword><Keyword MajorTopicYN="N">Protease-activated receptor 4</Keyword></KeywordList><CoiStatement>Conflict of interests. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31337508</ArticleId><ArticleId IdType="mid">NIHMS1535337</ArticleId><ArticleId IdType="pmc">PMC6739161</ArticleId><ArticleId IdType="doi">10.1016/j.cellimm.2019.103949</ArticleId><ArticleId IdType="pii">S0008-8749(19)30037-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antoniak S and Mackman N, Multiple roles of the coagulation protease cascade during virus infection. Blood, 2014. 123(17): p. 2605&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3999750</ArticleId><ArticleId IdType="pubmed">24632711</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin SR, Thrombin signalling and protease-activated receptors. Nature, 2000. 407(6801): p. 258&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001069</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S and Mackman N, Coagulation, protease-activated receptors, and viral myocarditis. J Cardiovasc Transl Res, 2014. 7(2): p. 203&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943797</ArticleId><ArticleId IdType="pubmed">24203054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn ML, et al., A dual thrombin receptor system for platelet activation. Nature, 1998. 394(6694): p. 690&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9716134</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrano GR, et al., Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature, 2001. 413(6851): p. 74&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11544528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S and Tran T, Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events. Cardiol Rev, 2015. 23(5): p. 261&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25923910</ArticleId></ArticleIdList></Reference><Reference><Citation>Weithauser A, et al., Protease-activated receptor 2 regulates the Innate Immune Response to Viral Infection in a CVB3-induced Myocarditis. J Am Coll Cardiol, 2013. 62(19): p. 1737&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077621</ArticleId><ArticleId IdType="pubmed">23871888</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S, et al., PAR-1 contributes to the innate immune response during viral infection. J Clin Invest, 2013. 123(3): p. 1310&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582138</ArticleId><ArticleId IdType="pubmed">23391721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhu QM, et al., Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol, 2010. 3(1): p. 29&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2851245</ArticleId><ArticleId IdType="pubmed">19865078</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoufache K, et al., PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3533265</ArticleId><ArticleId IdType="pubmed">23202729</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S, et al., Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice. J Innate Immun, 2017. 9(2): p. 181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5330934</ArticleId><ArticleId IdType="pubmed">27820939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al., Innate generation of thrombin and intracellular oxidants in airway epithelium by allergen Der p 1. J Allergy Clin Immunol, 2016. 138(4): p. 1224&#x2013;1227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5052125</ArticleId><ArticleId IdType="pubmed">27345173</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoufache K, et al., PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest, 2013. 123(1): p. 206&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3533265</ArticleId><ArticleId IdType="pubmed">23202729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmeier W, et al., Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis. Res Pract Thromb Haemost, 2018. 2(3): p. 407&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6046595</ArticleId><ArticleId IdType="pubmed">30046746</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoufache K, et al., Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol, 2009. 182(12): p. 7795&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">19494303</ArticleId></ArticleIdList></Reference><Reference><Citation>Rwibasira Rudinga G, Khan GJ, and Kong Y, Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. Int J Mol Sci, 2018. 19(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5855795</ArticleId><ArticleId IdType="pubmed">29443899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, et al., Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding. Sci Transl Med, 2017. 9(371).</Citation><ArticleIdList><ArticleId IdType="pubmed">28053157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolpakov MA, et al., Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury. J Mol Cell Cardiol, 2016. 90: p. 21&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5332160</ArticleId><ArticleId IdType="pubmed">26643815</ArticleId></ArticleIdList></Reference><Reference><Citation>Le VB, et al., Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med, 2015. 191(7): p. 804&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">25664391</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AG, et al., Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr, 2007. 137(5): p. 1236&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">17449587</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S, et al., Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6173317</ArticleId><ArticleId IdType="pubmed">30098988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsumi K, et al., Anticoagulation increases alveolar hemorrhage in mice infected with influenza A. Physiol Rep, 2016. 4(24).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210384</ArticleId><ArticleId IdType="pubmed">28003564</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S, et al., Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice. J Thromb Haemost, 2016. 14(6): p. 1238&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5892427</ArticleId><ArticleId IdType="pubmed">26947929</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi N, et al., Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease. Toxicology, 2016. 365: p. 9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5091088</ArticleId><ArticleId IdType="pubmed">27475285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer A, et al., Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab, 2011. 31(8): p. 1736&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170939</ArticleId><ArticleId IdType="pubmed">21386857</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K, et al., Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest, 1998. 78(10): p. 1227&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">9800948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, et al., CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circ Res, 2009. 104(5): p. 628&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">19168435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rullier A, et al., Expression of protease-activated receptors and tissue factor in human liver. Virchows Arch, 2006. 448(1): p. 46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16193294</ArticleId></ArticleIdList></Reference><Reference><Citation>Leipner C, et al., Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice. Med Microbiol Immunol, 2004. 193(2&#x2013;3): p. 141&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">14593475</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S, The coagulation system in host defense. Res Pract Thromb Haemost, 2018. 2(3): p. 549&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6046589</ArticleId><ArticleId IdType="pubmed">30046760</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrotto S, et al., Platelets interact with Coxsackieviruses B and have a critical role in the pathogenesis of virus-induced myocarditis. J Thromb Haemost, 2015. 13(2): p. 271&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">25393316</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabri A, et al., Mechanisms of protease-activated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. J Biol Chem, 2003. 278(13): p. 11714&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">12522105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S, et al., Thrombin and activated coagulation factor X stimulate the release of cytokines and fibronectin from nasal polyp fibroblasts via protease-activated receptors. Am J Rhinol Allergy, 2017. 31(1): p. 13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">28234145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleeschulte S, et al., Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose: PAR-4 in cardiac fibroblasts. Int J Cardiol, 2018. 252: p. 163&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">29249425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolattukudy PE, et al., Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol, 1998. 152(1): p. 101&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858131</ArticleId><ArticleId IdType="pubmed">9422528</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaquenod De Giusti C, et al., Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis. J Mol Cell Cardiol, 2015. 85: p. 58&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">26002282</ArticleId></ArticleIdList></Reference><Reference><Citation>Naldini A and Carney DH, Thrombin modulation of natural killer activity in human peripheral lymphocytes. Cell Immunol, 1996. 172(1): p. 35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">8806804</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava S, McVey JH, and Dorling A, The interface between coagulation and immunity. Am J Transplant, 2007. 7(3): p. 499&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">17229071</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutelier JP, et al., IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med, 1987. 165(1): p. 64&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2188250</ArticleId><ArticleId IdType="pubmed">3794607</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter VK and Griffin DE, Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis. J Gen Virol, 2016. 97(11): p. 2908&#x2013;2925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770845</ArticleId><ArticleId IdType="pubmed">27667782</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, et al., T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc Natl Acad Sci U S A, 2013. 110(34): p. E3216&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752276</ArticleId><ArticleId IdType="pubmed">23922396</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson WJ, et al., Destructive interactions between murine macrophages, tumor cells, and antibodies of the IgG2a isotype. Adv Exp Med Biol, 1985. 184: p. 75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">2931004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipps TJ, et al., Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med, 1985. 161(1): p. 1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2187540</ArticleId><ArticleId IdType="pubmed">3918141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Metcalf M, and Bunnett NW, Biased signaling of protease-activated receptors. Front Endocrinol (Lausanne), 2014. 5: p. 67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4026716</ArticleId><ArticleId IdType="pubmed">24860547</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Goffic R, et al., Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog, 2006. 2(6): p. e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1475659</ArticleId><ArticleId IdType="pubmed">16789835</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo C, et al., Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response. Virus Res, 2018. 257: p. 102&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">30248373</ArticleId></ArticleIdList></Reference><Reference><Citation>Suo Z, et al., Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J Biol Chem, 2003. 278(33): p. 31177&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">12775717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomides LF, et al., Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice. Inflamm Res, 2014. 63(11): p. 935&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">25118784</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, et al., Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. J Biol Chem, 2011. 286(5): p. 3805&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030382</ArticleId><ArticleId IdType="pubmed">21106537</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy RV, et al., Occupancy of human EPCR by protein C induces beta-arrestin-2 biased PAR1 signaling by both APC and thrombin. Blood, 2016. 128(14): p. 1884&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054700</ArticleId><ArticleId IdType="pubmed">27561318</ArticleId></ArticleIdList></Reference><Reference><Citation>Parameswaran N, et al., Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J Biol Chem, 2006. 281(45): p. 34159&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">16980301</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondina MT, et al., In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest, 2012. 141(6): p. 1490&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367488</ArticleId><ArticleId IdType="pubmed">22383669</ArticleId></ArticleIdList></Reference><Reference><Citation>Boilard E, et al., Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation. Blood, 2014. 123(18): p. 2854&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">24665136</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama MG, et al., Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury. J Virol, 2016. 90(4): p. 1812&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4733979</ArticleId><ArticleId IdType="pubmed">26637453</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S, Sparkenbaugh E, and Pawlinski R, Tissue factor, protease activated receptors and pathologic heart remodelling. Thromb Haemost, 2014. 112(5): p. 893&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4382753</ArticleId><ArticleId IdType="pubmed">25104210</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara M, et al., Activation of PAR4 induces a distinct actin fiber formation via p38 MAPK in human lung endothelial cells. J Histochem Cytochem, 2005. 53(9): p. 1121&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15923365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton JR, Frauman AG, and Cocks TM, Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res, 2001. 89(1): p. 92&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenberg MD, et al., Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol, 2004. 143(4): p. 443&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1575414</ArticleId><ArticleId IdType="pubmed">15451771</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Serio C, et al., Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism. Basic Clin Pharmacol Toxicol, 2007. 101(1): p. 63&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577318</ArticleId></ArticleIdList></Reference><Reference><Citation>Betts RJ, Mann TS, and Henry PJ, Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice. J Pharmacol Exp Ther, 2012. 343(3): p. 725&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">22988062</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr R 3rd, et al., Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms. Mol Pharmacol, 2016. 89(1): p. 94&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702101</ArticleId><ArticleId IdType="pubmed">26464325</ArticleId></ArticleIdList></Reference><Reference><Citation>Stampfuss JJ, Schror K, and Weber AA, Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin. Nat Med, 2003. 9(12): p. 1447; author reply 1447&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14647510</ArticleId></ArticleIdList></Reference><Reference><Citation>Covic L, et al., Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med, 2002. 8(10): p. 1161&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12357249</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>